Article Details

Relmada Therapeutics, Inc.'s (RLMD) CEO Sergio Traversa on Q1 2022 Results - Seeking Alpha

Retrieved on: 2022-05-08 19:55:10

Tags for this article:

Click the tags to see associated articles and topics

Relmada Therapeutics, Inc.'s (RLMD) CEO Sergio Traversa on Q1 2022 Results - Seeking Alpha. View article details on HISWAI: https://seekingalpha.com/article/4508819-relmada-therapeutics-inc-s-rlmd-ceo-sergio-traversa-on-q1-2022-results-earnings-call

Excerpt

Andrea Tan - Goldman Sachs. Yatin Suneja - Guggenheim Partners. Marc Goodman - SVB Leerink. Vamil Divan - Mizuho Securities.

Article found on: seekingalpha.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up